Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 90621 - 90640 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Canada | (L04AB06) golimumab (adm: P) | Simponi (prefilled syringe) | Liq/Liq. SC 50 mg / 0.5 mL,Millilitre / millilitre | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Spondylitis, Ankylosing;Colitis, Ulcerative;Arthritis, Rheumatoid | JAN |
| Canada | (L04AC05) ustekinumab (adm: P) | Jamteki | Liq/Liq. SC 90 mg/mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | JPC |
| Canada | (L04AC05) ustekinumab (adm: P) | Jamteki | Liq/Liq. SC 45 mg / 0.5 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | JPC |
| Canada | (L04AC05) ustekinumab (adm: P) | Wezlana | Liq/Liq. SC 45 mg / 0.5 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AGA |
| Canada | (L04AC05) ustekinumab (adm: P) | Wezlana | Liq/Liq. SC 90 mg/mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AGA |
| Canada | (L04AC05) ustekinumab (adm: P) | Wezlana IV | Liq/Liq. IV 45 mg / 0.5 mL,Vial / fiole | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AGA |
| Canada | (L04AC05) ustekinumab (adm: P) | Wezlana IV | Liq/Liq. IV 130 mg / 26 mL,Vial / fiole | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AGA |
| Canada | (L04AC05) ustekinumab (adm: P) | Steqeyma IV | Liq/Liq. IV 130 mg / 26 mL,Vial / fiole | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease | CLT |
| Canada | (L04AC05) ustekinumab (adm: P) | Steqeyma | Liq/Liq. SC 45 mg / 0.5 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease | CLT |
| Canada | (L04AC05) ustekinumab (adm: P) | Steqeyma | Liq/Liq. SC 90 mg/mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease | CLT |
| Canada | (L04AC07) tocilizumab (adm: P) | Actemra | Liq/Liq. IV 80 mg / 4 mL,Vial / fiole | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | HLR |
| Canada | (L04AC07) tocilizumab (adm: P) | Actemra | Liq/Liq. IV 200 mg / 10 mL,Vial / fiole | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | HLR |
| Canada | (L04AC07) tocilizumab (adm: P) | Actemra | Liq/Liq. IV 400 mg / 20 mL,Vial / fiole | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | HLR |
| Canada | (L04AC07) tocilizumab (adm: P) | Actemra (autoinjector) | Liq/Liq. SC 162 mg / 0.9 mL,Autoinjector / auto-injecteur | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | HLR |
| Canada | (L04AC07) tocilizumab (adm: P) | Actemra (prefilled syringe) | Liq/Liq. SC 162 mg / 0.9 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | HLR |
| Canada | (L04AC07) tocilizumab (adm: P) | Tyenne (autoinjector) | Liq/Liq. SC 162 mg / 0.9 mL,Autoinjector / auto-injecteur | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FKB |
| Canada | (L04AC07) tocilizumab (adm: P) | Tyenne (prefilled syringe) | Liq/Liq. SC 162 mg / 0.9 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FKB |
| Canada | (L04AC07) tocilizumab (adm: P) | Tyenne | Liq/Liq. SC 200 mg / 10 mL,Vial / fiole | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FKB |
| Canada | (L04AC07) tocilizumab (adm: P) | Tyenne | Liq/Liq. SC 400 mg / 20 mL,Vial / fiole | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FKB |
| Canada | (L04AC07) tocilizumab (adm: P) | Tyenne | Liq/Liq. SC 80 mg / 4 mL,Vial / fiole | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FKB |
Pages
